Antoine Adenis 
, MD, PhD1; Amit S. Kulkarni, PhD2; Gustavo C. Girotto , MD3; Christelle de la Fouchardiere , MD4; Helene Senellart, MD5; Hanneke W. M. van Laarhoven , MD, PhD6; Wasat Mansoor , MBChB, MRCP, PhD7; Raed Al-Rajabi, MD8; Josephine Norquist, MS2; Mayur Amonkar, PhD2; Shailaja Suryawanshi, PhD2; Pooja Bhagia, MBBS, MD2; and Jean-Philippe Metges, MD, Msc9
Read Abstract: Impact of Pembrolizumab Versus Chemotherapy as Second-Line Therapy for Advanced Esophageal Cancer on Health-Related Quality of Life in KEYNOTE-181
.png){kind=logo}
